UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 34

Sortiert nach

Negative pressure ventilation: a special application of expiratory ventilation assistance

Intensive care medicine experimental, 2019-05, Vol.7 (1), p.22-2, Article 22

2019

Volltextzugriff (PDF)

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein

Endocrinology (Philadelphia), 2009-05, Vol.150 (5), p.2368-2375

2009

Volltextzugriff (PDF)

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin[S]

Journal of lipid research, 2014-10, Vol.55 (10), p.2103-2112

2014

Volltextzugriff (PDF)

Niacin Reduces Atherosclerosis Development in APOE3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

PloS one, 2013-06, Vol.8 (6), p.e66467

2013

Volltextzugriff (PDF)

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism

The Journal of clinical investigation, 2007-11, Vol.117 (11), p.3583-3592

2007

Volltextzugriff (PDF)

Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE3Leiden transgenic mice

Journal of hypertension, 2007-12, Vol.25 (12), p.2454-2462

2007

Volltextzugriff (PDF)

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE3Leiden.CETP mice

Arteriosclerosis, thrombosis, and vascular biology, 2008-11, Vol.28 (11), p.2016

2008

Volltextzugriff (PDF)

PET imaging of disease progression and treatment effects in the experimental autoimmune encephalomyelitis rat model

Journal of Nuclear Medicine, 2014-08, Vol.55 (8), p.1330-1335

2014

Volltextzugriff (PDF)

PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE[S]

Journal of lipid research, 2014-11, Vol.55 (11), p.2370-2379

2014

Volltextzugriff (PDF)

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9[S]

Journal of lipid research, 2015-11, Vol.56 (11), p.2085-2093

2015

Volltextzugriff (PDF)

Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin

Circulation (New York, N.Y.), 2008-05, Vol.117 (19), p.2515-2522

2008

Volltextzugriff (PDF)

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE3Leiden.CETP mice

European heart journal, 2017-08, Vol.38 (32), p.2499-2507

2017

Volltextzugriff (PDF)

Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE3-Leiden.CETP Mice

The Journal of biological chemistry, 2010-08, Vol.285 (33), p.25168-25175

2010

Volltextzugriff (PDF)

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

European heart journal, 2015-01, Vol.36 (1), p.39-50

2015

Volltextzugriff (PDF)

Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice

Applied physiology, nutrition, and metabolism, 2012-04, Vol.37 (2), p.214

2012

Volltextzugriff (PDF)

Salsalate attenuates diet induced non‐alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes

British journal of pharmacology, 2015-11, Vol.172 (22), p.5293-5305

2015

Volltextzugriff (PDF)

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE3-Leiden.CETP mice

The Journal of nutritional biochemistry, 2013-08, Vol.24 (8), p.1423-1430

2013

Volltextzugriff (PDF)

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Biochemical pharmacology, 2012-09, Vol.84 (6), p.821-829

2012

Volltextzugriff (PDF)

Validation of Interventional Fiber Optic Spectroscopy With MR Spectroscopy, MAS-NMR Spectroscopy, High-Performance Thin-Layer Chromatography, and Histopathology for Accurate Hepatic Fat Quantification

Investigative radiology, 2012-04, Vol.47 (4), p.209-216

2012

Volltextzugriff (PDF)

Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising: A systematic review and meta-analysis of relevant preclinical studies and clinical trials

European journal of pharmacology, 2015-09, Vol.763 (Pt A), p.48-63

2015

Volltextzugriff (PDF)

Flow-controlled ventilation - a new and promising method of ventilation presented with a review of the literature

Anaesthesiology intensive therapy : official publication of the Polish Society of Anaesthesiology and Intensive Therapy, 2022-01, Vol.54 (1), p.62

2022

Volltextzugriff (PDF)

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy

Expert opinion on pharmacotherapy, 2004-02, Vol.5 (2), p.459-468

2004

Volltextzugriff (PDF)

Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE3Leiden.CETP transgenic mice with or without treatment with atorvastatin

Journal of hypertension, 2012-01, Vol.30 (1), p.107-116

2012

Volltextzugriff (PDF)

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of HighDensity Lipoprotein

Endocrinology (Philadelphia), 2009, Vol.150 (5), p.2368-2375

2009

Volltextzugriff (PDF)

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Liver international, 2020-11, Vol.40 (11), p.2860-2876

2020

Volltextzugriff (PDF)

1 – 25 von 34

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(30)

Publikationsform

Artikel
(34)

Sprache

Englisch
(34)
Japanisch
(9)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Animals
(28)
Life Sciences & Biomedicine
(28)
Mice
(18)
Mice, Transgenic
(18)
Female
(14)
Humans
(14)
Male
(10)
Atherosclerosis
(9)
Apolipoprotein E3 - Genetics
(7)
Cholesterol Ester Transfer Proteins - Genetics
(7)
Cholesterol Ester Transfer Proteins - Metabolism
(7)
Lipids
(7)
Liver - Drug Effects
(7)
Liver - Metabolism
(7)
Biochemistry & Molecular Biology
(6)
Biological And Medical Sciences
(6)
Cardiovascular System & Cardiology
(6)
Cholesterol
(6)
Triglycerides - Blood
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Negative pressure ventilation: a special application of expiratory ventilation assistance

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of High-Density Lipoprotein

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin[S]

Niacin Reduces Atherosclerosis Development in APOE3Leiden.CETP Mice Mainly by Reducing NonHDL-Cholesterol

Knockout of cytochrome P450 3A yields new mouse models for understanding xenobiotic metabolism

Olmesartan and pravastatin additively reduce development of atherosclerosis in APOE3Leiden transgenic mice

Niacin increases HDL by reducing hepatic expression and plasma levels of cholesteryl ester transfer protein in APOE3Leiden.CETP mice

PET imaging of disease progression and treatment effects in the experimental autoimmune encephalomyelitis rat model

PCSK9 inhibition fails to alter hepatic LDLR, circulating cholesterol, and atherosclerosis in the absence of ApoE[S]

Anacetrapib reduces (V)LDL cholesterol by inhibition of CETP activity and reduction of plasma PCSK9[S]

Torcetrapib Does Not Reduce Atherosclerosis Beyond Atorvastatin and Induces More Proinflammatory Lesions Than Atorvastatin

The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE3Leiden.CETP mice

Fenofibrate Increases Very Low Density Lipoprotein Triglyceride Production Despite Reducing Plasma Triglyceride Levels in APOE3-Leiden.CETP Mice

Anacetrapib reduces progression of atherosclerosis, mainly by reducing non-HDL-cholesterol, improves lesion stability and adds to the beneficial effects of atorvastatin

Gender-dependent effects of high-fat lard diet on cardiac function in C57Bl/6J mice

Salsalate attenuates diet induced non‐alcoholic steatohepatitis in mice by decreasing lipogenic and inflammatory processes

Resveratrol protects against atherosclerosis, but does not add to the antiatherogenic effect of atorvastatin, in APOE3-Leiden.CETP mice

Niacin reduces plasma CETP levels by diminishing liver macrophage content in CETP transgenic mice

Validation of Interventional Fiber Optic Spectroscopy With MR Spectroscopy, MAS-NMR Spectroscopy, High-Performance Thin-Layer Chromatography, and Histopathology for Accurate Hepatic Fat Quantification

Innovative pharmaceutical interventions in cardiovascular disease: Focusing on the contribution of non-HDL-C/LDL-C-lowering versus HDL-C-raising: A systematic review and meta-analysis of relevant preclinical studies and clinical trials

Flow-controlled ventilation - a new and promising method of ventilation presented with a review of the literature

Amlodipine and atorvastatin in atherosclerosis: a review of the potential of combination therapy

Aliskiren inhibits atherosclerosis development and improves plaque stability in APOE3Leiden.CETP transgenic mice with or without treatment with atorvastatin

Bexarotene Induces Dyslipidemia by Increased Very Low-Density Lipoprotein Production and Cholesteryl Ester Transfer Protein-Mediated Reduction of HighDensity Lipoprotein

Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative

Suchergebnisse filtern